key: cord-0729227-c8py5uc8 authors: Oyeyemi, Oyetunde T.; Okunlola, Oluyemi A.; Adebayo, Adebowale D. title: Assessment of schistosomiasis endemicity and preventive treatment on coronavirus disease 2019 outcomes in Africa date: 2020-11-21 journal: New Microbes New Infect DOI: 10.1016/j.nmni.2020.100821 sha: a5ab726c24ce97191f9fb63f5d5387d872cc52e3 doc_id: 729227 cord_uid: c8py5uc8 Since COVID-19 pandemic, attention has been drawn to the possible interactions between the deadly disease and a few other infections. Although schistosomiasis and other NTDs have been proposed to influence susceptibility to COVID-19, no study has looked into this. This study investigated the impact of schistosomiasis on the transmission of COVID-19, and also evaluated the role of Praziquantel (PZQ) treatment coverage on COVID-19 outcomes in African countries. The schistosomiasis endemicity and the preventive chemotherapy (PCT) coverage index statuses were obtained from the WHO databank. The COVID-19 data was obtained from COVID-19 Worldometer’s report. The data were adjusted and the percentage COVID-19 confirmed, active cases, recovery, and deaths were computed. The COVID-19 outcomes were evaluated relative to schistosomiasis endemicity and treatment coverage. COVID-19 outcomes, especially, the active cases and recovery rates were significantly improved in schistosomiasis non-endemic African countries (p < 0.05). While COVID-19 confirmed cases were significantly higher in countries with > 75% schistosomiasis PCT coverage index (p <0.05), improved COVID-19 outcomes were observed relative to active cases and recovery in countries with > 75% PCT coverage index (p >0.05). This study showed that schistosomiasis endemicity could be associated with negative COVID-19 outcomes and higher PZQ treatment coverage could reduce COVID-19 active cases and improve the recovery rate. The coronavirus disease 2019 (COVID 19) which became pandemic in the early year 24 2020 has caused a serious public health problem with significant disease burden and mortality 25 globally. The COVID-19 pandemic has reached every corner of the world and has inflicted 26 serious economic loss, strained the health care system, and negatively impacted education in 27 countries of the world [1] . The disease is currently rapidly spreading in many African countries 28 most affected by the neglected tropical diseases (NTDs). There is currently transmission of 29 COVID-19 in 57 countries in Africa with over 5 million active cases and about 600,000 deaths 30 [2]. 31 In the wake of the COVID-19 pandemic, the World Health Organization's COVID-19 32 guidelines have urged countries to pause the on-going NTDs intervention programs in many 33 African countries including that of schistosomiasis. Schistosomiasis is a waterborne disease and The QGIS 3.10 software was used to generate the spatial maps for the sampling dataset Where #̅ = Mean of observations in the endemic group for each COVID-19 outcome. 105 #̅ = Mean of observations in the non-endemic group for each COVID-19 outcome. ) and ) are the number of observations in the endemic and non-endemic groups, respectively. Equally, the one-way analysis of variance (ANOVA) was used to test for significant 108 differences in COVID-19 outcomes among the three schistosomiasis PCT coverage index. The using one-way analysis of variance (ANOVA) with F-Statistics was defined as: The ) / and 0 1 / represent the size of observation and sample mean of each of the three 113 PCT coverage groups respectively, while k, N and 0 1 denote the three independent 114 schistosomiasis PCT coverage groups, total number of data points, and the overall mean of the 115 total data points, respectively. Each of the hypotheses was tested at a 5% level of significance and where necessary, Post-Hoc 117 analysis was conducted using Duncan Multiple Range Test (DMRT). The spatial maps of schistosomiasis treatment coverage and COVID-19 pandemic 120 outcomes in African countries were presented in ( Fig. 1 and 2) . Generally, unfavorable COVID-121 19 pandemic outcomes were observed in schistosomiasis endemic African countries compared to 122 non-endemic countries (Table 1 ). There was a deviation from this general observation in confirm 123 and active COVID-19 cases relative to schistosomiasis treatment coverage in some countries 124 ( Fig. 1 and 2 Schistosomiasis continues to be a serious public health problem in Africa despite being 147 an old disease. The inability of many governments of Africa to fully implement integrated 148 preventive strategies marked by shortfalls in water hygiene and sanitation has made preventive 149 chemotherapy the prioritized schistosomiasis control option [14] . Schistosomiasis has been 150 reported to be closely related to some viral diseases such as HIV/AIDS and hepatitis [14, 15] . While it is relatively difficult to promote a multi-disease approach for the prevention of the It is important to state that the data adopted for these analyses did not take into COVID-19-related school 228 closings and risk of weight gain among children Neglected Tropical Diseases -profile for mass treatment of NTDs Neglected tropical diseases in sub-Saharan Africa: review of their 235 prevalence, distribution, and disease burden Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a 238 systematic review and meta-analysis Treatment Expert Group for COVID-19. Comorbidity and its impact on 1590 patients 241 with COVID-19 in China: a nationwide analysis COVID-19 in 243 HIV Investigators. COVID-19 in HIV investigators. COVID-19 in patients with HIV: 244 clinical case series HIV and schistosomiasis co-infection in African children Schistosomiasis, hepatitis B and hepatitis C co-infection Ruprecht 274 RM. Coinfection with Schistosoma mansoni reactivates viremia in rhesus macaques 275 with chronic simian-human immunodeficiency virus clade C infection Coinfection with hepatitis C virus and schistosomiasis: fibrosis 279 and treatment response Poliovirus 281 and other enteroviruses in children infected with intestinal parasites in Nigeria Regulation of the host immune system by helminth 284 parasites Polyparasitism and its impact on 287 the immune system